Clinical trial
Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung Cancer
NCT05223647
Study timeline
Study start (actual)2022-01-11Date precision: day
Registry last updated2026-01-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Small-cell Lung Cancerunresolved
Interventions
Thoracic radiotherapyPROCEDURE
Sponsors & collaborators
Norwegian University of Science and Technologylead sponsor
St. Olavs Hospitalcollaborator
Haukeland University Hospitalcollaborator
University Hospital of North Norwaycollaborator
Alesund Hospitalcollaborator
Helse Stavanger HFcollaborator
Oslo University Hospitalcollaborator
Helse Nord-Trøndelag HFcollaborator
Helse Fonnacollaborator
Drammen sykehuscollaborator
University Hospital, Akershuscollaborator
Erasmus Medical Centercollaborator
Sahlgrenska University Hospitalcollaborator
Karolinska University Hospitalcollaborator
Gävle Hospitalcollaborator
Sykehuset Innlandet HFcollaborator
North Estonia Medical Centrecollaborator
Nordlandssykehuset HFcollaborator
Landspitali University Hospitalcollaborator
Lund University Hospitalcollaborator
University Hospital, Linkoepingcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05223647 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.